Emmanuelle Mougenot

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

Astrid Lièvre, Anthony Turpin, Isabelle Ray‐Coquard et al. · European Journal of Cancer · 2020 · 164 citations · Full text

Medicine, Infectious Diseases, Oncology +14

Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event

Carolyn S.P. Lam, Anna Giczewska, Karen Sliwa et al. · JAMA Cardiology · 2020 · 82 citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Smoking increases the risk of post-acute COVID-19syndrome: Results from a French community-based survey

H. Barthélémy, Emmanuelle Mougenot, Martin Duracinský et al. · Tobacco Induced Diseases · 2022 · 33 citations · Full text

Public Health, Community Health, Community Medicine +12

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

Faı̈ez Zannad, Christopher M. O’Connor, Javed Butler et al. · The Lancet · 2025 · 32 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17

Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry

Ramesh Nadarajah, Peter Ludman, Yolande Appelman et al. · European Heart Journal - Quality of Care and Clinical Outcomes · 2022 · 22 citations · Full text

Medicine, Cardiology, Internal Medicine +17